Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

A Pilot Efficacy and Implementation Study of the Strengths Intervention Project (SIP)

14. oktober 2019 opdateret af: Children's Hospital of Philadelphia
The purpose of this study is to test a strengths-based intervention to be delivered in a primary care setting with adolescents and a parent. Investigators want to find out if the intervention can help parents and teens communicate. Specifically Investigators want to see if they can help parents and teens identify and build teen's strengths. Half the dyads will receive the educational materials in conjunction with their teen's well-child visit, while the other half will receive usual care at the well-child visit and receive the educational materials at the end of the study. Additionally, Investigators expect that a strengths-based intervention may also impact adherence to treatment in youth with a chronic illness. As such, Investigators will include a subgroup of teenagers diagnosed with asthma in this study, to assess whether the strengths-based intervention that the Investigators developed has an impact on adherence.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Recent research suggests that parents and adolescents report an interest in doctors facilitating increased parent-teen communication about teen strengths. However, little research focuses on how to address this need in a primary care setting. Content from subject matter experts along with data gathered from parents and teens were used to develop a novel strengths-based intervention to be tested in primary care.

The study intervention being examined is called the Strengths Intervention Project and includes a written pamphlet, a guided discussion activity, in-person/phone health coaching, and in-person or mailed health care provider endorsement and key messaging. Measures will be collected at baseline pre-intervention (T1), in clinic or over the phone at the time of the intervention (T2), approximately two weeks post-intervention (T3), and approximately 2 months post-intervention (T4). Daily diaries will also be utilized twice to gather data pre- and post- intervention. We will measure feasibility of clinic implementation of intervention, as well as influence of intervention on parent-teen communication and adolescent outcomes.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

174

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Forenede Stater
    • Pennsylvania
      • Philadelphia, Pennsylvania, Forenede Stater, 19104
        • The Children's Hospital of Philadelphia

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

13 år til 15 år (Barn)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Adolescent Criteria:

Inclusion Criteria:

  1. Teens age 13 to 15 years at the time of their upcoming well-child visit (Arm 1) OR Teens age 13 to 15 years at the time of their last well-child visit (Arm 2)
  2. Children's Hospital of Philadelphia (CHOP) primary care patient (Arm 1 and 2)
  3. Scheduled for a well-child visit that parent and teen both plan to attend (Arm 1) OR Attended a well-child visit with parent (Arm 2)
  4. Diagnosed with Asthma > year (asthma subgroup; Arm 1 only)
  5. Prescribed a controller medication year-round (asthma subgroup; Arm 1 only)
  6. Adolescent has their own email account to complete electronic surveys (Arm 1 and 2)

Exclusion Criteria:

  1. Not fluent in written or spoken English (Arm 1 and 2)
  2. Attending a new patient well-child visit (Arm 1) OR attended a new patient well-child visit (Arm 2)
  3. Presence of developmental delay or pervasive developmental disorder that requires special education services (Arm 1 and 2)
  4. Psychiatric hospitalization of the adolescent in the past year (Arm 1 and 2)
  5. Participated in studies: CHOP IRB # 15-011732 and/or CHOP IRB # 17-013895 (Arm 1 and 2)
  6. Adolescent has sibling enrolled in (IRB 18-014922) (Arm 1 and 2)

Parent Criteria:

Inclusion Criteria:

  1. Parent or legal guardian of a teen age 13 to 15 years at their upcoming well-child visit at a CHOP primary care practice (Arm 1) OR Parent or legal guardian of a teen age 13 to 15 years at their recent well-child visit at a CHOP primary care practice (Arm 2)
  2. Parent has their own email account to complete electronic surveys (Arm 1 and 2)

Exclusion Criteria:

  1. Not fluent in written or spoken English (Arm 1 and 2)
  2. Participated in studies: CHOP IRB # 15-011732 and/or CHOP IRB # 17-013895 (Arm 1 and 2)

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Andet
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Intervention Group (Arm 1- Main)
Will receive the "Build Your Teen's Strengths" educational pamphlet, health coaching sessions, and provider endorsement.
Adfærdsmæssigt: Build and Support Your Teen's Strengths
This is a clinic based psychoeducational intervention for adolescent patients and their parents to improve parent-teen communication about teen strengths. The intervention is designed, if possible, to coincide with the adolescent patients' well-child visits and consists of the following components: (1) In-person or over the phone orientation session with a trained health coach and parent, (2) Distribution of psychoeducational materials to the parent, (3) Endorsement and delivery of key messages from the health care provider, and (4) "Booster" phone call placed by the health coach.
Ingen indgriben: Control Group (Arm 1- Main)
Will receive usual care at well-child visit.
Eksperimentel: Intervention Group (Arm 1-asthma subgroup)
Will receive the "Build Your Teen's Strengths" educational pamphlet, health coaching sessions, and provider endorsement.
Adfærdsmæssigt: Build and Support Your Teen's Strengths
This is a clinic based psychoeducational intervention for adolescent patients and their parents to improve parent-teen communication about teen strengths. The intervention is designed, if possible, to coincide with the adolescent patients' well-child visits and consists of the following components: (1) In-person or over the phone orientation session with a trained health coach and parent, (2) Distribution of psychoeducational materials to the parent, (3) Endorsement and delivery of key messages from the health care provider, and (4) "Booster" phone call placed by the health coach.
Ingen indgriben: Control Group (Arm 1-asthma subgroup)
Will receive usual care at well-child visit.
Ingen indgriben: Control Group (Arm 2)
Convenience sample used for a post-hoc, exploratory analysis. Will receive usual care at well-child visit.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Beliefs about Adolescents
Tidsramme: Baseline (T1) and 2-months (T4)
26 items (parents only); Likert scale (1= very unlikely; 7= very, very likely)
Baseline (T1) and 2-months (T4)
Change in Parent-Adolescent Communication (PACS)
Tidsramme: Baseline (T1) and 2-months (T4)
20 items (parent and teens); Likert scale (1= strongly disagree; 5= strongly agree)
Baseline (T1) and 2-months (T4)
Change in Confidence in exploring and using adolescent's strengths
Tidsramme: Baseline (T1) and 2-months (T4)
15 items (parents and teens); Likert scale (1=strongly disagree; 5= strongly agree)
Baseline (T1) and 2-months (T4)
Feasibility of consent rates
Tidsramme: 9 months
Feasibility will be demonstrated by consent rates ≥60%
9 months
Feasibility of intervention implementation
Tidsramme: 1 month
Completion of core intervention components ≥ 70%.
1 month
Parent and adolescent acceptability of intervention materials
Tidsramme: 2-weeks post intervention (T3)
Adolescent and parent acceptability ratings ≥80%. Investigators will also elicit open-ended feedback.
2-weeks post intervention (T3)
Parent and adolescent acceptability of intervention materials (additional)
Tidsramme: 2-months post intervention (T4)
2 items (parents and teens); Yes/No/Not sure and Likert scale (1=very likely; 5 very unlikely)
2-months post intervention (T4)
Provider acceptability of intervention
Tidsramme: 9 months
Provider acceptability ratings ≥80%. Investigators will also elicit open-ended feedback.
9 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Psychological well-being using the Flourishing Scale
Tidsramme: Baseline (T1) and 2-months (T4)
Measure of psychological well-being. 8 items (parents and teens). (Likert scale 1= Strongly disagree; 2= Disagree; 3= Slightly disagree; 4= Mixed or neither agree nor disagree; 5= Slightly agree; 6= Agree; 7= Strongly agree). Score will be summed for range of 8 (Strong Disagreement with all items) to 56 (Strong Agreement with items). High scores signify that respondents view themselves in positive terms in important areas of functioning.
Baseline (T1) and 2-months (T4)
Change in Adherence to inhaled controller medication use
Tidsramme: Baseline (T1) and 2-months (T4)
2-items about adherence to inhaled controller medication use (parent and teen) will be assessed using the Visual analog scale (0-10).
Baseline (T1) and 2-months (T4)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Children's Hospital of Philadelphia

Samarbejdspartnere

John Templeton Foundation

Efterforskere

  • Ledende efterforsker: Victoria A Miller, PhD, Children's Hospital of Phiadelphia

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

4. maj 2018

Primær færdiggørelse (Faktiske)

31. maj 2019

Studieafslutning (Faktiske)

31. maj 2019

Datoer for studieregistrering

Først indsendt

21. marts 2018

Først indsendt, der opfyldte QC-kriterier

11. april 2018

Først opslået (Faktiske)

12. april 2018

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

15. oktober 2019

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

14. oktober 2019

Sidst verificeret

1. oktober 2019

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Andre undersøgelses-id-numre

  • 18-014922

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Meddelelse

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Indonesia

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner